These data suggest that the pathway of miR-483-5/ALCAM is a key regulator in HCC intrahepatic metastasis and that it can be used as a prognostic indicator and the base for tailored treatment (Lu et al., 2018). Here, ALCAM is linked to hepatocellular carcinoma.